BARABINO, LUCA
BARABINO, LUCA
Prediction of severe infections in chronic lymphocytic leukemia: a simple risk score to stratify patients at diagnosis
2024-01-01 Murru, Roberta; Galitzia, Andrea; Barabino, Luca; Presicci, Roberta; La Nasa, Giorgio; Caocci, Giovanni
Clinical course and features of persistent polyclonal B-cell lymphocytosis with BCL-6 amplification during pregnancy
2023-01-01 Galitzia, A; Murru, R; Caocci, G; Barabino, L; Azzena, A; Licheri, V M; Greco, M; La Nasa, G
Chronic graft vs. host disease and hypogammaglobulinemia predict a lower immunological response to the BNT162b2 mRNA COVID-19 vaccine after allogeneic hematopoietic stem cell transplantation
2022-01-01 Barabino, L; Galitzia, A; Murru, R; Caocci, G; Targhetta, C; Greco, M; Angioni, G; Mulas, O; Vacca, A; Piras, E; Frau, V; Costa, A; La Nasa, G
Patients with Chronic Lymphocytic Leukemia Have a Very High Risk of Ineffective Response to the BNT162b2 Vaccine
2022-01-01 Galitzia, Andrea; Barabino, Luca; Murru, Roberta; Caocci, Giovanni; Greco, Marianna; Angioni, Giancarlo; Mulas, Olga; Oppi, Sara; Massidda, Stefania; Costa, Alessandro; La Nasa, Giorgio
Ruxolitinib does not impair humoral immune response to COVID-19 vaccination with BNT162b2 mRNA COVID-19 vaccine in patients with myelofibrosis
2022-01-01 Caocci, Giovanni; Mulas, Olga; Mantovani, Daniela; Costa, Alessandro; Galizia, Andrea; Barabino, Luca; Greco, Marianna; Murru, Roberta; La Nasa, Giorgio
Should be a Third Dose of BNT162b2 mRNA COVID-19-Vaccine Administered in Patients with Myelofibrosis Under Ruxolitinib?
2021-01-01 Caocci, Giovanni; Mulas, Olga; Mantovani, Daniela; Costa, Alessandro; Galitzia, Andrea; Barabino, Luca; Greco, Marianna; Murru, Roberta; La Nasa, Giorgio
| Titolo | Data di pubblicazione | Autore(i) | Rivista | Editore |
|---|---|---|---|---|
| Prediction of severe infections in chronic lymphocytic leukemia: a simple risk score to stratify patients at diagnosis | 1-gen-2024 | Murru, Roberta; Galitzia, Andrea; Barabino, Luca; Presicci, Roberta; La Nasa, Giorgio; Caocci, Giovanni | ANNALS OF HEMATOLOGY | - |
| Clinical course and features of persistent polyclonal B-cell lymphocytosis with BCL-6 amplification during pregnancy | 1-gen-2023 | Galitzia, A; Murru, R; Caocci, G; Barabino, L; Azzena, A; Licheri, V M; Greco, M; La Nasa, G | EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES | - |
| Chronic graft vs. host disease and hypogammaglobulinemia predict a lower immunological response to the BNT162b2 mRNA COVID-19 vaccine after allogeneic hematopoietic stem cell transplantation | 1-gen-2022 | Barabino, L; Galitzia, A; Murru, R; Caocci, G; Targhetta, C; Greco, M; Angioni, G; Mulas, O; Vacca, A; Piras, E; Frau, V; Costa, A; La Nasa, G | EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES | - |
| Patients with Chronic Lymphocytic Leukemia Have a Very High Risk of Ineffective Response to the BNT162b2 Vaccine | 1-gen-2022 | Galitzia, Andrea; Barabino, Luca; Murru, Roberta; Caocci, Giovanni; Greco, Marianna; Angioni, Giancarlo; Mulas, Olga; Oppi, Sara; Massidda, Stefania; Costa, Alessandro; La Nasa, Giorgio | VACCINES | - |
| Ruxolitinib does not impair humoral immune response to COVID-19 vaccination with BNT162b2 mRNA COVID-19 vaccine in patients with myelofibrosis | 1-gen-2022 | Caocci, Giovanni; Mulas, Olga; Mantovani, Daniela; Costa, Alessandro; Galizia, Andrea; Barabino, Luca; Greco, Marianna; Murru, Roberta; La Nasa, Giorgio | ANNALS OF HEMATOLOGY | - |
| Should be a Third Dose of BNT162b2 mRNA COVID-19-Vaccine Administered in Patients with Myelofibrosis Under Ruxolitinib? | 1-gen-2021 | Caocci, Giovanni; Mulas, Olga; Mantovani, Daniela; Costa, Alessandro; Galitzia, Andrea; Barabino, Luca; Greco, Marianna; Murru, Roberta; La Nasa, Giorgio | BLOOD | - |